Transcranial Low Intensity Focused Ultrasound Neuromodulation as a Probe to Study Human Emotion and Cognitive Function
Not Applicable
Not yet recruiting
- Conditions
- Depressive Disorder, Major
- Interventions
- Device: LIFUP sonication to the amygdala
- Registration Number
- NCT05194332
- Brief Summary
The purpose of this study is to assess the low-intensity focused ultrasound pulsation (LIFUP) neuromodulation on emotion processing in healthy individuals, and to assess the overall safety of the LIFUP to stimulate or inhibit brain activity in healthy volunteers.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
- Must be right-handed
- Must be illicit drug-free at the time of scanning as appropriate (verified by negative urine drug screen)
- Must be healthy (without medical, neurological, psychiatric illness)
- Must be psychotropic medication free (≥ 14 days)
Exclusion Criteria
- Must not be a smoker
- Females must not be pregnant or nursing
- Must not suffer from claustrophobia
- Must not meet exclusion criteria for MRI scanning (i.e., non-fixed magnetizable objects)
- Must not have ongoing, chronic, or relapsing/remitting medical, psychiatric,or neurological illness as determined by a combination of history, medical record, and/or examination.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description LIFUP sonication to the amygdala LIFUP sonication to the amygdala -
- Primary Outcome Measures
Name Time Method Changes in amygdala activity indicated by functional magnetic resonance imaging (fMRI) scan blood oxygen-level-dependent (BOLD) signal baseline, 5 mins post-LIFUP sonication Changes in brain resting state functional network as indicated by fMRI scan connectivity measures baseline, 10-20 mins post-LIFUP sonication
- Secondary Outcome Measures
Name Time Method Change in performance on Reward Task baseline, 1-hour post-LIFUP sonication Tolerability of LIFUP sonication as assessed number of adverse events baseline, immediately after LIFUP sonication
Trial Locations
- Locations (1)
The University of Texas Health Science Center at Houston
🇺🇸Houston, Texas, United States